Jayson Donald Alexander Dallas Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jayson Donald Alexander Dallas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jayson Donald Alexander Dallas. Jayson Donald Alexander Dallas is Director in ARENA PHARMACEUTICALS INC ($ARNA) and EVP & Chief Commercial Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and See Remarks in Ultragenyx Pharmaceutical Inc. ($RARE) and President and CEO in Aimmune Therapeutics, Inc. ($AIMT).
Latest Insider Trading Transactions of Jayson Donald Alexander Dallas
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, ARNA, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Sell | S | 80.50 | 1,327 | 106,824 | 5,308 | 6.6 K to 5.3 K (-20.00 %) |
| Jan 20 2021 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Sell | S | 80.50 | 1,327 | 106,824 | 5,308 | 6.6 K to 5.3 K (-20.00 %) |
| Dec 15 2020 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Buy | P | 69.31 | 5 | 347 | 6,635 | 6.6 K to 6.6 K (+0.08 %) |
| Dec 09 2020 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Buy | P | 66.25 | 5 | 331 | 6,630 | 6.6 K to 6.6 K (+0.08 %) |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | D | 23.81 | 200,000 | 4,762,000 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | D | 23.72 | 210,000 | 4,981,200 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | D | 30.68 | 350,000 | 10,738,000 | 0 | |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Sell | D | 34.50 | 89,250 | 3,079,125 | 0 | 89.3 K to 0 (-100.00 %) |
| Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Sell | U | 34.50 | 30,422 | 1,049,559 | 0 | 30.4 K to 0 (-100.00 %) |
| Sep 16 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Payment of Exercise | F | 34.25 | 1,642 | 56,239 | 117,034 | 118.7 K to 117 K (-1.38 %) |
| Jun 26 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Payment of Exercise | F | 18.02 | 7,907 | 142,484 | 118,676 | 126.6 K to 118.7 K (-6.25 %) |
| Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
| Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Grant | A | 0.00 | 2,446 | 0 | 6,625 | 4.2 K to 6.6 K (+58.53 %) |
| May 12 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 3,300 | 0 | 126,583 | 123.3 K to 126.6 K (+2.68 %) |
| Mar 10 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Buy | P | 18.74 | 2,665 | 49,934 | 123,283 | 120.6 K to 123.3 K (+2.21 %) |
| Mar 04 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Payment of Exercise | F | 23.81 | 3,081 | 73,359 | 120,618 | 123.7 K to 120.6 K (-2.49 %) |
| Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | A | 23.81 | 200,000 | 4,762,000 | 200,000 | |
| Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 33,000 | 0 | 123,699 | 90.7 K to 123.7 K (+36.38 %) |
| Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
| Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Sell | S | 56.51 | 170 | 9,606 | 4,179 | 4.3 K to 4.2 K (-3.91 %) |
| Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Sell | S | 55.82 | 1,355 | 75,634 | 4,349 | 5.7 K to 4.3 K (-23.76 %) |
| Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Grant | A | 0.00 | 2,654 | 0 | 5,704 | 3.1 K to 5.7 K (+87.02 %) |
| Feb 26 2019 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | A | 23.72 | 210,000 | 4,981,200 | 210,000 | |
| Feb 26 2019 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 35,000 | 0 | 98,650 | 63.7 K to 98.7 K (+54.99 %) |
| Nov 19 2018 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Buy | P | 27.56 | 50 | 1,378 | 63,650 | 63.6 K to 63.7 K (+0.08 %) |
| Nov 19 2018 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Buy | P | 27.56 | 3,600 | 99,209 | 63,600 | 60 K to 63.6 K (+6.00 %) |
| Jun 19 2018 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | A | 30.68 | 350,000 | 10,738,000 | 350,000 | |
| Jun 19 2018 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
| Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
| Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Grant | A | 0.00 | 3,050 | 0 | 3,050 | 0 to 3.1 K |
| Jun 04 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 73.73 | 294 | 21,677 | 23,830 | 24.1 K to 23.8 K (-1.22 %) |
| Apr 19 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Grant | A | 0.00 | 1,431 | 0 | 23,604 | 22.2 K to 23.6 K (+6.45 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Option Exercise | A | 48.43 | 32,000 | 1,549,760 | 32,000 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 48.43 | 441 | 21,358 | 22,173 | 22.6 K to 22.2 K (-1.95 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Grant | A | 0.00 | 6,500 | 0 | 22,614 | 16.1 K to 22.6 K (+40.34 %) |
| Aug 07 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 62.59 | 940 | 58,835 | 16,107 | 17 K to 16.1 K (-5.51 %) |
| Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 56.61 | 320 | 18,115 | 17,047 | 17.4 K to 17 K (-1.84 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Option Exercise | A | 88.80 | 30,000 | 2,664,000 | 30,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Grant | A | 0.00 | 4,500 | 0 | 16,960 | 12.5 K to 17 K (+36.12 %) |
| Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 1.46 | 41,666 | 60,832 | 41,666 | |
| Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Dallas Jayson Donald Alexander | Director | Option Exercise | A | 1.46 | 75,000 | 109,500 | 75,000 | |
| Aug 08 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Payment of Exercise | F | 64.24 | 940 | 60,386 | 12,460 | 13.4 K to 12.5 K (-7.01 %) |
| Jun 07 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Option Exercise | A | 69.53 | 11,000 | 764,830 | 11,000 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Option Exercise | A | 70.57 | 20,200 | 1,425,514 | 20,200 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Grant | A | 0.00 | 3,400 | 0 | 13,400 | 10 K to 13.4 K (+34.00 %) |
| Aug 06 2015 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Option Exercise | A | 116.45 | 90,000 | 10,480,500 | 90,000 | |
| Aug 06 2015 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1